Exabis Library
Welcome to the e-CCO Library!
P306: Faecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn’s disease regardless of disease location
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P306: MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P306: Serum tryptophan metabolites as a biomarker for disease severity in patients with IBD
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P306: The real-life experience of vedolizumab efficacy and safety in ulcerative colitis: a prospective observational multicentre cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P306: What is the impact of perianal disease on anorectal function and quality of life of IBD patients? A prospective observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P307: Fecal Lactoferrin levels are stable during pregnancy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P307: High frequency of Deep Infiltrating Endometriosis in patients with Inflammatory Bowel Disease: a nested case-control study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P307: Modelling of the relationship between ustekinumab exposure, faecal calprotectin and endoscopic outcomes in patients with Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P307: Safety, efficacy, and pharmacokinetics of golimumab in patients with moderately to severely Active ulcerative colitis: PURSUIT-SC long-term extension
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P307: Study of the proteomic profile in patients with ulcerative colitis, its correlation with diagnosis and disease activity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P307: The effect of COVID-19 infection and vaccination in patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P307: The use of the patient safety form in patients with inflammatory bowel disease, can improve the low screening and starting HBV prophylaxis rates in real life
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P308 The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P308: A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: SOUL study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P308: Continued statural growth In older adolescents and young adults with Crohn’s disease and ulcerative colitis beyond the time of expected growth plate closure
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P308: Effectiveness and Safety of tofacitinib for the Treatment of Ulcerative Colitis: A Single-Arm Meta-analysis of Observational Studies
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P308: Predictors of loss of response to adalimumab therapy: the importance of therapeutic drug monitoring in inflammatory bowel diseases
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P308: Quadruple oral antibiotic treatment in refractory Paediatric Inflammatory Bowel Disease – incidence and analysis of responders from a 10 year cohort.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P308: Safety of the given patency capsule in patients with Crohn's disease or suspected Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM